drugset / Trial / NCT01011036

Effects of GABA-a-Agonists on Pain Mechanisms: An Experimental Study in Healthy Volunteers

NCT01011036

Phase 3 Completed 17 enrolled Insel Gruppe AG, University Hospital Bern
RandomizedCrossoverTriple-blindTreatment

Summary

The investigators will use an intradermal capsaicin injection in the forearm to induce a state of localized pain. This localized pain will be measured by different means, and analysed locally and distally by so called quantitative sensory testing. The primary endpoint of measure is the difference in pain perception with and without benzodiazepines/GABA-Agonists around the injection point of capsaicin. The secondary endpoints are to measure pain modulation locally and distally by different quantitative tests as electricity, pressure pain thresholds, and ice water tests. The investigators' hypothesis is that clobazam induces higher pain thresholds as placebo and less sedation than the control medication clonazepam.

Timeline

Start
2009-12
Primary completion
2010-04
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Clobazam Small molecule 20 mg
Subject Clonazepam Small molecule 1 mg
Subject Tolterodine Small molecule 1 mg

Indications

No indication recorded.